BioCentury
ARTICLE | Company News

NeoStem, Phase III Medical deal

January 30, 2006 8:00 AM UTC

PHSM acquired stem cell bank NeoStem for 5 million PHSM shares. The deal values NeoStem at $37,500 using PHSM's close of $0.075 on Jan. 25, the day before the closing was announced. ...